Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis | Zendy

Sara Llufriú | Zendy; John Kornak | Zendy; H. Ratiney | Zendy; Joonmi Oh | Zendy; Don Brenneman | Zendy; Bruce Cree | Zendy; Mehul Sampat | Zendy; Stephen L. Hauser | Zendy; Sarah J. Nelson | Zendy; Daniel Pelletier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis

Author(s) -

Sara Llufriú,

John Kornak,

H. Ratiney,

Joonmi Oh,

Don Brenneman,

Bruce Cree,

Mehul Sampat,

Stephen L. Hauser,

Sarah J. Nelson,

Daniel Pelletier

Publication year - 2014

Publication title -

jama neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.298

H-Index - 231

eISSN - 2168-6157

pISSN - 2168-6149

DOI - 10.1001/jamaneurol.2014.895

Subject(s) - multiple sclerosis , astrogliosis , medicine , white matter , brain size , magnetic resonance imaging , expanded disability status scale , hyperintensity , atrophy , cohort , pathology , central nervous system , immunology , radiology

Predicting disease evolution is becoming essential for optimizing treatment decision making in multiple sclerosis (MS). Multiple sclerosis pathologic damage typically includes demyelination, neuro-axonal loss, and astrogliosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research